NTX-303 / PinotBio - LARVOL DELTA

[VIRTUAL] Paget ‘s Disease: Not So Typical for Atypical Femur Fracture (ENDO 2021) - "Her medications were primidone, levothyroxine, lisinopril-hydrochlorothiazide, and vitamin D. She did not smoke tobacco or drink alcohol...Urine NTx 303 BCE/mM Cr (<89)...She was given zoledronic acid 5 mg IV...The ASBMR task force recommended that bisphosphonates should be discontinued in patients with bisphosphonate-associated AFF due to their severely suppressed bone turnover status. On the other hand, the AFF in patients with PD may heal in response to bisphosphonate treatment."

CNS Disorders • Endocrine Disorders • Epilepsy • Hypertension • Immunology • Musculoskeletal Diseases • Orthopedics • Osteoarthritis • Otorhinolaryngology • Pain • Rheumatology

Pinobio enters 3 clinical trials…ADC platform technology is being developed [Google translation] (Hankyung) - "Pinobio...announced that it will enter the clinical trials of the expansion cohort of NTX-303, a solid cancer treatment, from the first half of next year. NTX-303 is undergoing phase 1 and 2 clinical trials led by the National Cancer Institute (NCI)...'The blood cancer treatment NTX-301 will be conducting phase 1a clinical trials in Korea from the second half of next year.'"

New P1 trial • New trial • Trial status • Hematological Malignancies • Oncology • Solid Tumor